e-learning
resources
Virtual 2020
Pre-Congress Content
Multidrug-resistant tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
TREATMENT OF MDR-TB PATIENTS WITH DELETION POLYMORPHISM OF XENOBIOTICS DETOXICATION SYSTEM GENES OF GLUTATHIONE-S-TRANSFERASE
I. Semianiv (Chernivtsi, Ukraine), L. Todoriko (Chernivtsi, Ukraine), M. Semianiv (Chernivtsi, Ukraine)
Source:
Virtual Congress 2020 – Multidrug-resistant tuberculosis
Session:
Multidrug-resistant tuberculosis
Session type:
E-poster session
Number:
470
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Semianiv (Chernivtsi, Ukraine), L. Todoriko (Chernivtsi, Ukraine), M. Semianiv (Chernivtsi, Ukraine). TREATMENT OF MDR-TB PATIENTS WITH DELETION POLYMORPHISM OF XENOBIOTICS DETOXICATION SYSTEM GENES OF GLUTATHIONE-S-TRANSFERASE. 470
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
DEVELOPMENT OF A DIGITAL TELEREHABILITATION SOLUTION: ANALYSIS OF THE NEEDS OF PATIENTS WITH CHRONIC DISEASES
Source: International Congress 2017 – Latest insights into chronic care
Year: 2017
FACTORS INFLUENCING PHARMACOLOGICAL TREATMENT IN COPD PATIENTS ENROLED IN AN INTEGRATED DISEASE MANAGEMENT PROGRAMME (IDMP)
Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet?
Year: 2018
NEBULIZER AEROSOL DRUG DELIVERY THROUGH HIGH FLOW NASAL CANNULA IN ADULT PATIENTS
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020
ASSOCIATION OF EXERCISE CAPACITY AND ENDOTHELIAL FUNCTION IN PATIENTS WITH FIBROSING INTERSTITIAL LUNG DISEASE
Source: Virtual Congress 2021 – Peripheral muscle function, exercise capacity and functional status in respiratory disease
Year: 2021
HEART VARIABILITY IN THE PRESENCE OF PSYCHOLOGICAL STRESS AND QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020
OBSTACLE OF PHYSICAL ACTIVITY AND ACTIVITIES OF DAILY LIVING IN PATIENTS WITH COPD: DYSPNEA RELATED KINESIOPHOBIA
Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients
Year: 2019
PSYCHOLOGICAL FACTORS PREDICTIVE OF QUALITY OF LIFE IN PATIENTS WITH INTERSTITIAL PULMONARY DISEASE
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Year: 2020
DYNAMICS OF GLUTATION SYSTEM INDICATORS IN CHRONIC LUNG DISEASES ON MODEL INHALED TREATMENT
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020
EFFICACY OF IRON REPLETION WITHOUT ERYTHROPOIESIS-STIMULATING AGENT IN PATIENTS WITHCHEMOTHERAPY-INDUCED ANEMIA IN LUNG CANCER
Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Year: 2018
INCREASED MYOSTATIN AS A NEGATIVE REGULATOR OF MUSCLE REGENERATION POTENTIAL IN SARCOPENIC COPD PATIENTS: CLINICAL IMPLICATIONS
Source: Virtual Congress 2020 – Best abstracts in the field of pulmonary rehabilitation
Year: 2020
PSYCHOLOGICAL FACTORS PREDICTIVE OF QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: Virtual Congress 2020 – Prognosis and integrated management of COPD
Year: 2020
OPPORTUNITIES FOR PREVENTIVE TREATMENT OF CHILDREN WITH LATENT TUBERCULOSIS INFECTION FROM FOCUS WITH MDR-TB
Source: International Congress 2019 – Paediatric tuberculosis
Year: 2019
THE IMPACT OF PULMONARY REHABILITATION ON PHYSICAL ACTIVITY AND PHYSICAL FITNESS LEVELS IN LUNG TRANSPLANT CANDIDATES; PRELIMINARY STUDY RESULTS
Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases
Year: 2017
A COMPARATIVE STUDY ON EFFECTS OF SUBSTANCE DEPENDENCE ON PULMONARY TUBERCULOSIS PATIENTS
Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities
Year: 2021
DISCREPANCY ACROSS PHENOTYPIC AND GENOTYPIC RESULTS OF DRUG SUSCEPTIBILITY TESTING OF MYCOBACTERIUM TUBERCULOSIS
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018
EXPIRATORY FLOW LIMITATION BY IMPULSE OSCILLOMETRY SYSTEM EVALUATION IN SEVERE OBESITY WOMEN
Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients
Year: 2019
DIFFERENCES OF ANXIETY, DEPRESSION AND FUNCTIONAL CAPACITY BETWEEN PATIENTS WITH CARDIORESPIRATORY FAILURE WITH PARTIAL AND TOTAL ADHERENCE
Source: Virtual Congress 2020 – Pulmonary function and rehabilitation in non-respiratory disease
Year: 2020
FUNCTIONAL AND METABOLIC CHARACTERISTICS OF BRONCHOALVEOLAR LAVAGE FLUID CELLS IN PATIENTS WITH PROLONGED COMMUNITY ACQUIRED PNEUMONIA
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021
EVALUATION OF RESPIRATORY IMPEDANCE AND VENTILATORY HOMOGENEITY IN PATIENTS WITH PRETERM BIRTH
Source: International Congress 2018 – Paediatric bronchology
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept